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Does moderate exercise
prevent MI for patients 
with coronary heart disease?
■ EVIDENCE-BASED ANSWER
Moderate exercise reduces mortality for patients
with known coronary heart disease but does not
significantly decrease the risk of recurrent nonfa-
tal myocardial infarction (MI) (strength of recom-
mendation [SOR]: A, based on systematic review
of randomized controlled trials). Exercise-based
cardiac rehabilitation also reduces all-cause mor-
tality (SOR: A, based on systematic review). 
For patients with stable angina, a daily exer-
cise program is more effective than percutaneous
transluminal coronary angioplasty (PTCA) with
stenting in preventing major cardiovascular
events (number needed to treat [NNT]=5.5; SOR:
A, based on a single randomized controlled trial).
■ EVIDENCE SUMMARY
A systematic review of cardiac rehabilitation pro-
grams evaluated 14 randomized controlled trials
with exercise-based interventions.1 An updated
review added 5 more for a total of 2984 patients
with coronary heart disease.2 Patients with coro-
nary heart disease comprised those with prior
MI, prior coronary artery bypass graft surgery, or
PTCA, and those with angina pectoris and angio-
graphically confirmed coronary heart disease.
Exercise-based cardiac rehabilitation signifi-
cantly reduced all-cause mortality (relative risk
[RR]=0.76; 95% confidence interval [CI],
0.59–0.98) compared with usual care (NNT=66;
95% CI, 35–273). Cardiac mortality also
decreased significantly with exercise (RR=0.73;
95% CI, 0.56–0.96) compared with usual care
(NNT=49; 95% CI, 26–120).  
Six studies showed particularly significant
improvement in total cardiac mortality.3–8 Exercise
was variably defined. Training sessions lasted 30
minutes and occurred on 2 to 5 days per week.
Intensity was typically 75% to 85% of a maximum
work capacity determined on an exercise test before
initiating the training sessions. The type of exer-
cise ranged from cycling alone to circuit training
with 6 stationary devices. Patients were trained
with supervision 1 to 36 months and followed for
a mean of 24 months (range, 6–60 months). 
A trend was observed toward decreased recur-
rence of nonfatal MI with exercise-based cardiac
rehabilitation, which did not reach significance
(RR=0.78; 95% CI, 0.59–1.03). An inadequate
number of subjects is the most likely reason; how-
ever, other possibilities include an increase in the
frequency of nonfatal MI after rehabilitation, or an
increased rate of survival after MI for patients
undergoing exercise-based rehabilitation.
The studies included in these reviews had sev-
eral limitations. The population appears skewed in
age (mean=54 years, with patients aged >65 years
excluded from most studies) and gender (4.9%
female); ethnicity was rarely reported. The adequa-
cy of randomization was poor or unclear in 71% of
studies, and only 4 trials reported blind assessment
of outcomes. Finally, in 34% of studies the loss of
participants to follow-up was more than 20%.
A well-done study randomized 101 male
patients (age <70 years) with stable angina to
C L I N I C A L  I N Q U I R I E S
either a daily exercise program or standard PTCA
with stenting.9 After 12 months, event-free sur-
vival was significantly greater among patients
randomized to exercise than in those randomized
to PTCA with stenting (88% vs 70%; P=.023;
NNT=5.5). Cardiovascular events were defined as
percutaneous interventions, hospitalizations,
acute MI, cerebrovascular accidents, coronary
artery bypass graft operation, and death.
■ RECOMMENDATION FROM OTHERS
The American Heart Association (AHA) supports
aggressive risk factor management for patients
with coronary heart disease, and recommends a
minimum of 30 minutes of exercise 3 to 4 days per
week as well as an increase in daily lifestyle activ-
ities.10 The American College of Cardiology
endorses the position of the AHA.
Rodney Riedel, MD, Gary Kelsberg, MD, Valley Family
Medicine, Renton, Wash; Sarah Greenley, Information
Specialist, Clinical Evidence, BMJ Publishing Group, London
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■ CLINICAL COMMENTARY:
Add exercise to routine post-MI treatment
We should add exercise to routine post-MI
treatment checklists, along with aspirin, beta-
blockers, statins, angiotensin-converting enzyme
inhibitors, and so on. Precise exercise prescrib-
ing requires a stress test because, as the adage
goes, “If we don’t do an exercise test with mon-
itoring, the patient will eventually do one
unmonitored at home.”
Medicare pays for cardiac rehabilitation for
acute MI (within 6 months), coronary artery
bypass (within a year), and stable angina. Other
insurance reimbursement varies.
The evidence isn’t the quality I would like,
and for women and minorities it is lacking.
However, evidence sticklers like USPSTF11
state that exercise reduces morbidity and mor-
tality for (almost) everyone. The question is
how to make exercise happen; people with CHD
can often be motivated.
Bill Kerns, MD, Shenandoah Valley Family Practice
Residency, Virginia Commonwealth University/Medical
College of Virginia, Winchester
DRUG BRAND NAMES
Amiodarone  •  Cordarone
Atenolol  •  Tenormin
Atorvastatin  •  Lipitor
Diclofenac  •  Cataflam, Voltaren
Disopyramide  •  Norpace
Dofetilide  •  Tikosyn
Enoxaparin  •  Lovenox
Flecainide •  Tambocor
Metoprolol  •  Lopressor
Propafenone  •  Rythmol
Simvastatin  •  Zocor
Solatol  •  Betapace
Warfarin  •  Coumadin
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